Publicaciones en las que colabora con José Luis Martín Ventura (12)

2016

  1. Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential

    Expert Review of Proteomics, Vol. 13, Núm. 9, pp. 857-871

2011

  1. Animal models of cardiovascular diseases

    Journal of Biomedicine and Biotechnology, Vol. 2011

2010

  1. Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes

    Diabetes, Vol. 59, Núm. 6, pp. 1292-1301

2008

  1. Proteomics in atherosclerosis

    Current Atherosclerosis Reports, Vol. 10, Núm. 3, pp. 209-215

2007

  1. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques

    European Journal of Pharmacology, Vol. 562, Núm. 1-2, pp. 119-129

  2. Characterization of the human atheroma plaque secretome by proteomic analysis

    Methods in Molecular Biology, Vol. 357, pp. 141-150

2006

  1. Modulación mediante tratamiento con atorvastatina y/o amlodipino del perfil de proteínas liberadas por placas ateroscleróticas humanas

    Clínica e investigación en arteriosclerosis, Vol. 18, Núm. 5, pp. 167-175

2005

  1. Quest for novel cardiovascular biomarkers by proteomic analysis

    Journal of Proteome Research, Vol. 4, Núm. 4, pp. 1181-1191

2003

  1. Proteomic analysis of human vessels: Application to atherosclerotic plaques

    Proteomics

  2. Simvastatin reduces NF-κB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet

    Cardiovascular Research, Vol. 57, Núm. 1, pp. 168-177

2002

  1. Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells

    Atherosclerosis, Vol. 160, Núm. 1, pp. 49-58

2001

  1. Simvastatin reduces inflammation in rabbit atheroma more markdely than dietary lipid lowering

    Investigacion Cardiovascular, Vol. 4, Núm. 1, pp. 28-42